JAFL
PMVP icon

Jay A. Fishman Ltd’s PMV Pharmaceuticals PMVP Stock Holding History

Jay A. Fishman Ltd’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-70,000
Closed -$113K – 90
2024
Q2 		$113K Sell
70,000
-10,000
-13% -$18K 0.01% 86
2024
Q1 		$136K Buy
80,000
+50,000
+167% +$93.4K 0.02% 90
2023
Q4 		$93K Hold
30,000
– – 0.01% 91
2023
Q3 		$184K Hold
30,000
– – 0.02% 92
2023
Q2 		$188K Buy
30,000
+5,000
+20% +$26.2K 0.02% 95
2023
Q1 		$119K Buy
25,000
+5,000
+25% +$35.2K 0.02% 91
2022
Q4 		$174K Buy
20,000
+10,000
+100% +$107K 0.02% 91
2022
Q3 		$119K Buy
+10,000
New +$144K 0.02% 88

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jay A. Fishman Ltd's PMVP Position: Q3 2024 in Review

Jay A. Fishman Ltd sold out of PMV Pharmaceuticals (PMVP) in Q3 2024, closing a stake of 70,000 shares — an estimated $113K sold.

Jay A. Fishman Ltd first reported a position in PMVP in Q3 2022 and held it in 8 quarters. The position peaked at $188K in Q2 2023. 74 funds tracked by Wall St. Rank hold PMVP as of Q3 2024.

  • Jay A. Fishman Ltd reported no remaining PMV Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Jay A. Fishman Ltd sold 70,000 PMV Pharmaceuticals shares in Q3 2024, an estimated $113K.
  • Jay A. Fishman Ltd first reported a position in PMV Pharmaceuticals in Q3 2022 and held it in 8 quarters.
  • Jay A. Fishman Ltd's PMV Pharmaceuticals position peaked at $188K in Q2 2023.
  • 74 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2024.

Based on Jay A. Fishman Ltd's 13F filing for Q3 2024, filed 30 Oct 2024.